|
from the injections menu
Injectable products
on the European market
(The following is taken from the March 1998 Newsletter of the European Society for Sexual and Impotence Research and is provided merely to give the European citizen a resource for further and more current research.)
ANDROSKAT (Byk Netherland bv)
Registered in:
Belgium Luxembourg, Germany, Spain, Denmark, Finland, Italy and Portugal
Available on the market:
The Netherlands and Austria
Formulation:
Per 1ml 15mg Papaverine Hydrochloride 0.5mg Phentolamine Mesylate
Special devices attached to medication:
Available in the form of ampoules and cartridges. Kits include syringes with long needles and short needles, alcohol swabs and in the case of Andropen, an autoinjection device which is easy to use for the patient. Andropen can only be used together with cartridges.
VIRIDAL (DUO /EDEX - Schwarz Pharma)
Registered in:
France, United Kingdom, Ireland, Russia, Germany, Finland and Denmark
Awaiting registration in:
Italy, Spain, Sweden and Norway
Formulation:
(Alprostadil-alfadex [prostaglandin E1 - (cyclo-dextrine] )
Special devices attached to medication:
Ampoules, reusable applicator, 30 G needles, alcohol swabs, two chamber carpules (10, 20 mcg), vials (5,10,20 mcg)
CAVERJECT (Pharmacia & Upjohn)
Registered in:
Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Russia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Ukraine and United Kingdom
Awaiting registration in:
Croatia, Estonia, Kazakstan, Latvia, Lithuania, Poland, Turkey and Uzbekistan
Formulation:
Alprostadil 5,10,20 mcg
Special devices attached to medication:
Adis-posable syringe prefilled with diluent, a 5,10,20 mcg vial of Caverject sterile powder, two needles Becton Dickinson MICROLANCE 3 (27G x 1/2 and 22G x 1 1/2), two alcohol swabs
Peninject 2.25, an autoinjector device, is also distributed by
Pharmacia & Upjohn for exclusive use with Caverject.
ERECNOS (Fournier)
Registered in:
France and Great Britain
Awaiting registration in:
Austria, Belgium, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Portugal, Spain, Sweden and Holland
Formulation:
10 mg/1 ml and 20 mg/1 ml Chlorhydrate of Moxisylyte
Special devices attached to medication:
dual chamber preloaded syringes.
|
|
